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introduction: Sleep-disordered breathing (SDB) is increasingly associated with cardiovascular disorders, including acute myocardial infarction 
(AMI). An important consequence of SDB is excessive daytime sleepiness (EDS). In light of growing evidences that EDS may predict cardiovascular 
outcomes, and a favorable response to treatment of SDB, we therefore sought to investigate the association of SDB, cardiac biomarkers, and EDS in 
patients with acute myocardial infarction (AMI).
methods: We conducted an observational cohort study of 137 consecutive patients who were hospitalized with AMI. Each patient underwent object 
and subjective sleep evaluation with portable sleep monitoring and administration of the Epworth Sleepiness Scale (ESS) to measure EDS. We used 
an apnea-hypopnea index (AHI) cutoff of ≥5 events/hour to diagnose SDB and sleepiness was defined as an ESS > 10. Data are presented as mean 
± standard deviation unless otherwise specified. Linear regression analysis was used to assess the correlation between continuous variables.
results: Mean age was 61.3 ± 13 years, BMI was 29.9 ± 7 kg/m2 and 67% were males. The overall prevalence of SBD was 63% and 34% had EDS. 
The correlation between AHI and ESS was low (r2=0.02;p=0.07) and there was no significant difference in ESS score among patients with versus 
without SDB (9.6±0.6 vs 8.1±0.8; p=0.12). The lack of association between ESS and AHI persisted using different AHI cutoffs (7.9±0.9 for AHI<5; 
9.0±1.1 for AHI≥5 and <15; 9.1±1.1 for AHI≥15 and <30; 10.5±1.0 for AHI≥30; p=0.3). Furthermore, patients who reported EDS also tended to 
have lower peak troponin levels (2.4±3 vs 3.6±5 ng/mL; p=0.06).
Conclusion: SDB is highly prevalent in patients with AMI. Despite a high prevalence of SDB, most patients did not report EDS. In the setting of 
an acute MI, EDS does not appear to correlate with severity of SDB is associated with lower peak troponin levels. Further research is needed to 
investigate whether SDB and sleepiness affect the natural history of AMI.
